These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22951216)

  • 61. How to Interpret Antiphospholipid Laboratory Tests.
    Devreese KMJ
    Curr Rheumatol Rep; 2020 Jun; 22(8):38. PubMed ID: 32562091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
    Roubey RA
    Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 65. How to diagnose and manage antiphospholipid syndrome.
    Hubben A; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):606-613. PubMed ID: 38066904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI.
    Iverson GM; von Mühlen CA; Staub HL; Lassen AJ; Binder W; Norman GL
    J Autoimmun; 2006 Dec; 27(4):266-71. PubMed ID: 17081732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays.
    Devreese KM; Van Hoecke F
    Thromb Res; 2011 Dec; 128(6):598-600. PubMed ID: 21762962
    [No Abstract]   [Full Text] [Related]  

  • 68. Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.
    Tortosa C; Cabrera-Marante O; Serrano M; Martínez-Flores JA; Pérez D; Lora D; Morillas L; Paz-Artal E; Morales JM; Pleguezuelo D; Serrano A
    PLoS One; 2017; 12(7):e0178889. PubMed ID: 28727732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
    Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants.
    Favaloro EJ
    Int J Lab Hematol; 2013 Jun; 35(3):269-74. PubMed ID: 23590654
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions.
    Favaloro EJ; Wong RC
    Semin Thromb Hemost; 2008 Jun; 34(4):389-410. PubMed ID: 18814073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort.
    Boffa MC; Boinot C; De Carolis S; Rovere-Querini P; Aurousseau MH; Allegri F; Nicaise-Roland P; Barra A; Botta A; Ambrozic A; Avcin T; Tincani A
    Thromb Haemost; 2009 Jul; 102(1):25-8. PubMed ID: 19572063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anticardiolipin IgA as a Potential Risk Factor for Pregnancy Morbidity in Patients with Antiphospholipid Syndrome.
    Zhai X; Yang S; Cui L
    Lab Med; 2022 Sep; 53(5):495-499. PubMed ID: 35640241
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interpretation and recommended testing for antiphospholipid antibodies.
    Galli M
    Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Decavele AS; Schouwers S; Devreese KM
    Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process.
    Bruno V; Nuccetelli M; Ticconi C; Bruno A; Martelli F; Capogna MV; Bernardini S; Piccione E; Pietropolli A
    Reprod Biol Endocrinol; 2019 Oct; 17(1):79. PubMed ID: 31615575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.